Two Target Regions of Allelic Loss on Chromosome 9 in Urinary-bladder Cancer
β Scribed by Ohgaki, Kenji ;Minobe, Kaori ;Kurose, Keisuke ;Iida, Aritoshi ;Habuchi, Tomonori ;Ogawa, Osamu ;Kubota, Yoshinobu ;Akimoto, Masao ;Emi, Mitsuru
- Book ID
- 108581808
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1999
- Tongue
- English
- Weight
- 157 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study has analysed 65 urothelial carcinomas for allelic imbalance at 22 loci of chromosome 5 and has determined three regions of interest. A commonly duplicated region was mapped to chromosome 5p between loci D5S1473 and D5S819, one region of deletion to chromosome 5q22Β±23 between loci D5S2055
Like most cancers, prostate cancer (CaP) is believed to be the result of the accumulation of genetic alterations within cells. Previous studies have implicated numerous chromosomal regions with elevated rates of allelic imbalance (AI), using mostly primary CaPs with an unknown disease outcome. These
Our main purpose was to identify tumor suppressor gene loci on chromosome 13 responsible for nasopharyngeal cancer (NPC) development by analyzing loss of heterozygosity (LOH) and RB protein expression in paraffin embedded tissues. Normal and tumor DNA were extracted from microdissected samples, and
Allelic loss on chromosome 9 is the most frequent and earliest genetic event in bladder carcinogenesis, and its detection in urine samples would be useful for detecting bladder cancer. A highly sensitive method to detect loss of heterozygosity (LOH) at 5 polymorphic loci on chromosome 9p and 9q was